Beverly D Smolich - JoVE Visualize

Showing results (1-10 of 5) with videos related to

Pageof 1

Sort By:

Evolution; International Journal of Organic Evolution|May 31, 2017

EVOLUTION AND MITOCHONDRIAL DNA IN NEUROSPORA CRASSAJohn W Taylor, Beverly D Smolich, Georgiana May

Oncogene|February 27, 2004

Gene expression profiling of human colon xenograft tumors following treatment with SU11248, a multitargeted tyrosine kinase inhibitorAlyssa M Morimoto, Nguyen Tan, Kristina West, et al.

BMC Cancer|March 27, 2003

Expression profiling of blood samples from an SU5416 Phase III metastatic colorectal cancer clinical trial: a novel strategy for biomarker identificationSamuel E DePrimo, Lily M Wong, Deepak B Khatry, et al.

Blood|September 28, 2002

SU5416 and SU5614 inhibit kinase activity of wild-type and mutant FLT3 receptor tyrosine kinaseKevin W H Yee, Anne Marie O'Farrell, Beverly D Smolich, et al.

Blood|January 18, 2003

SU11248 is a novel FLT3 tyrosine kinase inhibitor with potent activity in vitro and in vivoAnne-Marie O'Farrell, Tinya J Abrams, Helene A Yuen, et al.

Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:

Pageof 1

Evolution; International Journal of Organic Evolution|May 31, 2017

EVOLUTION AND MITOCHONDRIAL DNA IN NEUROSPORA CRASSAJohn W Taylor, Beverly D Smolich, Georgiana May

Oncogene|February 27, 2004

Gene expression profiling of human colon xenograft tumors following treatment with SU11248, a multitargeted tyrosine kinase inhibitorAlyssa M Morimoto, Nguyen Tan, Kristina West, et al.

BMC Cancer|March 27, 2003

Expression profiling of blood samples from an SU5416 Phase III metastatic colorectal cancer clinical trial: a novel strategy for biomarker identificationSamuel E DePrimo, Lily M Wong, Deepak B Khatry, et al.

Blood|September 28, 2002

SU5416 and SU5614 inhibit kinase activity of wild-type and mutant FLT3 receptor tyrosine kinaseKevin W H Yee, Anne Marie O'Farrell, Beverly D Smolich, et al.

Blood|January 18, 2003

SU11248 is a novel FLT3 tyrosine kinase inhibitor with potent activity in vitro and in vivoAnne-Marie O'Farrell, Tinya J Abrams, Helene A Yuen, et al.

Pageof 1